190 CHAPTER 9 18. Shen NN, Zhang C, Hang Y, Li Z, Kong LC, Wang N, et al. Real-world prevalence of direct oral anticoagulant off-label doses in atrial fibrillation: An epidemiological meta-analysis. Front Pharmacol. 2021;12:581293. 19. Santos J, António N, Rocha M, Fortuna A. Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: A systematic review. Br J Clin Pharmacol. 2020;86:533–47. 20. Joosten LPT, Van Maanen R, Van Den Dries CJ, Rutten FH, Hoes AW, Granger CB, et al. Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Open Heart. 2023;10(1):e002197. 21. La Roi-Teeuw HM, Van Smeden M, Bos M, De Wilde SM, Yang B, Rutten FH, et al. Estimated causal effects of common respiratory infections on cardiovascular risk: A meta-analysis. Open Heart. 2023;10(2):e002501. 22. Peltzer B, Manocha KK, Ying X, Kirzner J, Ip JE, Thomas G, et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19. J Cardiovasc Electrophysiol. 2020;31(12):3077–85. 23. Mountantonakis SE, Saleh M, Fishbein J, Gandomi A, Lesser M, Chelico J, et al. Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection. Heart Rhythm. 2021;18(4):501–7. 24. Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439–44. 25. Offerhaus JA, Joosten LPT, van Smeden M, Linschoten M, Bleijendaal H, Tieleman R, et al. Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients. IJC Heart and Vasculature. 2022;39:100970. 26. Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SAE, Woodward M, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: Systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013. 27. Musikantow DR, Turagam MK, Sartori S, Chu E, Kawamura I, Shivamurthy P, et al. Atrial fibrillation in patients hospitalized with COVID-19: Incidence, predictors, outcomes, and comparison to Influenza. JACC Clin Electrophysiol. 2021;7(9):1120–30. 28. Sukumar S, Gulilat M, Linton B, Gryn SE, Dresser GK, Alfonsi JE, et al. Apixaban concentrations with lower than recommended dosing in older adults with atrial fibrillation. J Am Geriatr Soc. 2019;67(9):1902–6. 29. Eidam A, Marji J, Benzinger P, Foerster KI, Burhenne J, Czock D, et al. Frailty as a marker for the plasma concentrations of direct oral anticoagulants in older patients: Results of an exploratory study. Drugs Aging. 2023;40(2):153–64. 30. Hart JT. The inverse care law. The Lancet. 1971;27(1(7696)):405–12. 31. Centraal Bureau voor de Statistiek. Bevolking op 1 januari en gemiddeld; geslacht, leeftijd en regio. [Internet]. 2023 [cited 2024 Feb 17]. Available from: https://www.cbs.nl/nl-nl/ cijfers/detail/03759ned?dl=39E0B 32. Centraal Bureau voor de Statistiek. Ouderen. [Internet]. 2023 [cited 2024 Feb 17]. Available from: https://www.cbs.nl/nl-nl/visualisaties/dashboard-bevolking/leeftijd/ouderen 33. Vektis. Factsheet kwetsbare ouderen. [Internet]. 2020 [cited 2024 Feb 17]. Available from: https://www.vektis.nl/intelligence/publicaties/factsheet-kwetsbareouderen#:~:text=17%25%20van%20alle%20thuiswonende%2065,%25)%20van%20 alle%20thuiswonende%20ouderen. 34. Wilkinson C, Todd O, Clegg A, Gale CP, Hall M. Management of atrial fibrillation for older people with frailty: A systematic review and meta-analysis. Age and Ageing. Oxford University Press; 2019;48:196–204.
RkJQdWJsaXNoZXIy MTk4NDMw